Clinical Trial Update: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a biological medicine for diffuse intrinsic pontine glioma and related diffuse midline gliomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma H3 K27-altered
• Diffuse Midline Glioma H3 K27m-mutant

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 3 | Status: RECRUITING